Composition for Treating Spermatogenesis and Semen Disorders / FPT-20
Condition: Spermatogenesis and Semen Disorders
MeSH terms: Infertility
Study type: Interventional

Summary: 
      Research to develop a new, natural-derived formulation that eliminates inflammatory tissue
      and regenerates new tissue of the lobules, epithelium of the tubules, and connective tissue
      surrounding the seminiferous tubules in the testes. It restores Leydig cells and Sertoli
      cells' function (because the inflamed testicles were unable to perform spermatogenesis).
    

Detailed description: 
      FPT-20 has stabilized cortisol levels, maintained stable B-lymphocytes in the body, verified
      by quantitative tests of blood B-lymphocytes and blood cortisol, cut off the chronic
      inflammation chain, promoted the regeneration of the epithelium of the coiled ducts, and
      repairs the connective tissue surrounding the coils.

      Select a type of flavonoid that has the ability to protect human body cells by destroying
      toxic proteins. Targeted flavonoids are selected for multiple simultaneous effects, acting as
      a chemotactic or physiological modifier. Many studies have shown that flavonoids can also act
      as cell cycle inhibitors, which can also cause cancer cell death at an early stage (at the
      stage of a few cells). There have been many documents demonstrating that some flavonoids have
      the ability to kill cancer cells, stabilize stages of cell differentiation, and improve
      immunity. Flavonoids present in FPT-20 protect and regenerate cells, clean up inflammatory
      and fibrotic cells, and facilitate the growth of germ cells.

      The selected flavonoids in the preparation are also used to regenerate the epithelium in the
      lumen of the seminiferous tubules, ensure the perfusion of the lobules, and stabilize the
      spermatogenesis process.

      FPT-20 is easily distributed in high concentrations in immune cells. It has natural
      antibacterial activity, promotes lymphocyte proliferation, and is rapidly consumed during
      inflammation. The effects show a prominent role in the regulation of the immune system, and
      there is a high degree of interaction, which requires more research to understand its
      mechanism, FPT-20 will not be effective in the absence of one of the components selected to
      participate in the test.

      FPT-20 will reach its therapeutic effect after 6-12 months. After 6-12 months, an amount of
      progressively motile sperm was found in the semen.

      According to research, FPT-20 created a homeostasis, protecting cell membranes, cutting off
      the cell's inflammatory chain, and preventing transcription and translation errors. The
      mediators regulated the protective responses in the body. Cytokines that have a beneficial
      effect through specific receptors, and many other unexplained processes, have altered the
      spermatogenesis status of the testes. The body will absorb the components in FPT-20 through
      the small intestine wall, this metabolism has created a significant amount of B lymphocytes
      to provide for the process of restoring the function of the testicles. An appropriately
      calculated dose of FPT-20 is provided during the treatment, using precursors, enzymes, and
      flavonoids available in nature to supplement and interfere with biochemical processes taking
      place in the body. The extracts in the preparation should be used regularly (>6 months) until
      the therapeutic purpose is achieved. The product has offered hope to patients who are unable
      to produce sperm from spermatogonia (because the process has been disrupted). Stabilize the
      semen pH within good limits, to produce high-quality sperm as well as to achieve efficiency
      into egg penetration.
    

Intervention name(s): FPT-20
Intervention type(s): Drug
Intervention description(s): FPT-20 should be used regularly, the daily maintenance dose is 1 tablet once a day(>6 to 12 months) until the therapeutic purpose is achieved.
Intervention model: Single Group Assignment
Intervention model description: The number of infertile people after recruitment was divided into 2 groups.
Spermatogenesis.
Male infertility group due to lack of sperm.
Masking: None (Open Label)
Primary purpose: Supportive Care
Keywords: Spermatogenesis; Male infertility; Orchitis; Mumps virus; Hypogonadism